Startups
Theratechnologies is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. We currently market prescription products in the United States and Canada. Our research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, oncology and NASH.
Overview
Location
Canada, Quebec, Montreal
Employees
51-200
Founded date
1993
Mentions in press and media 10
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 2, 2024 | Theratechnologies Secures up to $75 Million in New Credit Facilities with TD Bank and Investissement Québec | New financing replaces existing credit facility to optimize Company’s capital structure Favorable interest rates and amortization schedules to free up approximately $19 million in cash in 2025 to support business development strategy MONTRE... |
| Feb 2, 2023 | What Is The Connection Between Tesamorelin And Diabetes? | David Thompson, Tech Times 02 February 2023, 11:02 am (Photo : Towfiqu barbhuiya on Unsplash) What is the connection between Tesamorelin and diabetes is the subject of today's article. If you are interested in finding out the answer, then k... |
| Nov 23, 2021 | Theratechnologies Announces Renewal of Shelf Prospectus and Registration Statement; At-The-Market Facility to be Extended | MONTREAL, Nov. 23, 2021 /PRNewswire/ - Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative th... |
| May 20, 2021 | THERATECHNOLOGIES INC. Theratechnologies : Announces Results from Two Posters Presented at ACTHIV2021 Annual Meeting Highlighting Positive Patient Experience with Trogarzo® | THERATECHNOLOGIES ANNOUNCES RESULTS FROM TWO POSTERS PRESENTED AT ACTHIV 2021 ANNUAL MEETING HIGHLIGHTING POSITIVE PATIENT EXPERIENCE WITH TROGARZO® 100% of patients expressed satisfaction with treatment experience 98% compliance observed w... |
| Feb 25, 2021 | Theratechnologies : Financial Statements | Consolidated Financial Statements (In thousands of United States dollars) THERATECHNOLOGIES INC. November 30, 2020 and 2019 THERATECHNOLOGIES INC. Table of Contents (In thousands of United States dollars) Page Consolidated Statements of Fin... |
| Feb 25, 2021 | THERATECHNOLOGIES INC. Theratechnologies : Financial Statements | Consolidated Financial Statements (In thousands of United States dollars) THERATECHNOLOGIES INC. November 30, 2020 and 2019 THERATECHNOLOGIES INC. Table of Contents (In thousands of United States dollars) Page Consolidated Statements of Fin... |
| Feb 25, 2021 | THERATECHNOLOGIES INC. Theratechnologies : MD&A | ANNUAL INFORMATION FORM Financial Year Ended November 30, 2020 February 24, 2021 BASIS OF PRESENTATION In this Annual Information Form, or AIF: references to "Theratechnologies", the "Company", the "Corporation&qu... |
| Feb 25, 2021 | Theratechnologies : MD&A | ANNUAL INFORMATION FORM Financial Year Ended November 30, 2020 February 24, 2021 BASIS OF PRESENTATION In this Annual Information Form, or AIF: references to "Theratechnologies", the "Company", the "Corporation&qu... |
| Jan 25, 2021 | Piramal Pharma Solutions Announces Sterile Fill/Finish Program with Theratechnologies Inc. for TH1902 Peptide-drug Conjugate USA - English USA - English USA - English USA - English Italia - Italiano France - Français España - español Deutschland - Deutsch |
Reviews 0
FAQ about Theratechnologies Inc.
When was Theratechnologies Inc. founded?
Theratechnologies Inc. was founded in 1993.
What has the press written about Theratechnologies Inc.?
Parsers VC has collected 10 articles mentioning Theratechnologies Inc., among them “Theratechnologies Secures up to $75 Million in New Credit Facilities with TD Bank and Investissement Québec” (Dec 2, 2024) and “What Is The Connection Between Tesamorelin And Diabetes?” (Feb 2, 2023).
Is Theratechnologies Inc. still active?
Yes, Theratechnologies Inc. is active; its latest activity on Parsers VC dates from Jun 30, 2025.